Family Medicine · Lafayette, LA
NPI
1114959442
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
202 Westgate Rd
Lafayette, LA, 70506
Phone (337) 232-1802
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
777 services
Medicare patients, 2024
227
Average age 80
Drug cost, 2024
$1.5M
12,710 prescriptions
Company payments, 2025
$2,207
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geoffrey A Mire was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 137 times for 95 patients. In total Geoffrey A Mire billed 777 services in 35 codes, and Medicare paid $43K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 137 | 95 | $10.77 | $1,476 |
| 99308 SNF E&M | Facility | 98 | 72 | $45.01 | $4,411 |
| 99306 SNF E&M | Facility | 81 | 81 | $135.76 | $11K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 77 | 77 | $120.18 | $9,254 |
| 99309 SNF E&M | Facility | 69 | 57 | $77.61 | $5,355 |
| 99213 Office E&M - Established | Office | 61 | 24 | $52.03 | $3,174 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 58 | 11 | $0.66 | $38.49 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 58 | 24 | $10.62 | $616 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 19 | 19 | $120.26 | $2,285 |
| 99212 Office E&M - Established | Office | 14 | 12 | $38.45 | $538 |
| 90471 Vaccine Administration | Office | 13 | 11 | $12.51 | $163 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 13 | 11 | $0.08 | $1.02 |
By year: 2022 $51K for 737 services; 2023 $49K for 720 services; 2024 $43K for 777 services.
Medicare prescription drug claims, 2024
In 2024, the drug Geoffrey A Mire prescribed most often to Medicare patients was Atorvastatin Calcium, with 447 prescriptions and refills. In total Geoffrey A Mire wrote 12,710 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 447 | 491 | 59 | $4,526 |
| Eliquis Apixaban | 418 | 418 | 33 | $124K |
| Namzaric Memantine Hcl/Donepezil Hcl | 408 | 408 | 20 | $121K |
| Levothyroxine Sodium Generic | 376 | 419 | 43 | $3,287 |
| Rosuvastatin Calcium Generic | 349 | 407 | 59 | $5,694 |
| Gabapentin Generic | 320 | 320 | 49 | $3,874 |
| Amlodipine Besylate Generic | 316 | 364 | 53 | $2,151 |
| Farxiga Dapagliflozin Propanediol | 312 | 316 | 19 | $97K |
| Montelukast Sodium Generic | 222 | 236 | 32 | $2,409 |
| Clopidogrel Clopidogrel Bisulfate | 215 | 215 | 30 | $1,955 |
| Metoprolol Succinate Generic | 212 | 220 | 31 | $4,081 |
| Tamsulosin Hcl Generic | 202 | 228 | 33 | $2,384 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 198 | 198 | 35 | $4,198 |
| Lisinopril Generic | 197 | 213 | 27 | $1,507 |
| Rexulti Brexpiprazole | 189 | 189 | 15 | $135K |
Brand drugs: 3,794 claims; generic drugs: 8,884 claims; opioid claims: 416.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geoffrey A Mire $2,207 ($2,207 in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $432.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $432 |
| GlaxoSmithKline, LLC. GSK | 19 | $271 |
| Lilly USA, LLC LLY | 10 | $157 |
| Astellas Pharma US Inc 4503.T | 7 | $141 |
| Novo Nordisk Inc NVO | 9 | $140 |
| Corium, LLC | 13 | $125 |
| Axsome Therapeutics, Inc. AXSM | 4 | $116 |
| Noven Therapeutics, LLC | 5 | $97.76 |
| Verona Pharma, Inc. VRNA | 4 | $93.3 |
| Phathom Pharmaceuticals, Inc. PHAT | 8 | $93.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.